L
Lipidor AB
F:L7R
Lipidor AB
F:L7R
Price:
0.0073
EUR
Market Closed
Market Cap:
€5.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lipidor AB
F:L7R
|
SE |
|
J
|
Jasuindo Tiga Perkasa Tbk PT
IDX:JTPE
|
ID |
|
Nutralife Biosciences Inc
OTC:NLBS
|
US |
|
Cyber App cCorp
OTC:CYRB
|
KR |
|
Amarc Resources Ltd
XTSX:AHR
|
CA |
Balance Sheet
Balance Sheet Decomposition
Lipidor AB
Lipidor AB
Balance Sheet Decomposition is not available for
Lipidor AB
Lipidor AB
Balance Sheet
Lipidor AB
Lipidor AB
Currency: SEK
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
1
|
27
|
64
|
51
|
9
|
1
|
10
|
|
| Cash |
1
|
1
|
27
|
64
|
51
|
9
|
1
|
10
|
|
| Total Receivables |
4
|
16
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
4
|
16
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
5
|
18
|
28
|
65
|
53
|
11
|
2
|
11
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
1
|
4
|
1
|
0
|
|
| Total Assets |
5
N/A
|
18
+297%
|
28
+56%
|
66
+133%
|
55
-16%
|
16
-72%
|
3
-82%
|
12
+310%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
1
|
1
|
2
|
2
|
5
|
0
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
9
|
11
|
6
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
1
|
4
|
1
|
2
|
11
|
13
|
12
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
4
+239%
|
1
-61%
|
2
+51%
|
11
+417%
|
13
+17%
|
12
-10%
|
4
-68%
|
|
| Equity | |||||||||
| Common Stock |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Retained Earnings |
35
|
42
|
56
|
72
|
94
|
135
|
147
|
160
|
|
| Additional Paid In Capital |
32
|
41
|
82
|
135
|
136
|
136
|
136
|
167
|
|
| Other Equity |
6
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
14
+316%
|
27
+86%
|
64
+137%
|
44
-32%
|
2
-95%
|
9
N/A
|
8
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
18
+297%
|
28
+56%
|
66
+133%
|
55
-16%
|
16
-72%
|
3
-82%
|
12
+310%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
24
|
24
|
24
|
28
|
110
|
110
|
110
|
813
|
|
Switch to:
Switch to:
See Also
Discover More
